{
    "id": "priority_serotonin_syndrome_vs_nms_priority_v2026",
    "type": "multipleChoice",
    "stem": "Based on the findings presented in the tabs, which action should the nurse take FIRST?",
    "options": [
        {
            "id": "a",
            "text": "Immediately discontinue the administration of the new medication (buspirone) and contact the healthcare provider to discuss the patient's symptoms and potential interventions for serotonin syndrome."
        },
        {
            "id": "b",
            "text": "Administer an antipyretic medication, such as acetaminophen, to address the elevated temperature and monitor for a response."
        },
        {
            "id": "c",
            "text": "Initiate a cooling blanket and apply ice packs to the patient's axillae and groin to aggressively manage the hyperthermia."
        },
        {
            "id": "d",
            "text": "Prepare to administer a dose of a muscle relaxant, such as dantrolene, to counteract the patient's muscle rigidity and hypertonicity."
        }
    ],
    "correctOptionId": "a",
    "itemContext": {
        "tabs": [
            {
                "tabTitle": "SBAR",
                "tabContent": "S: Patient is a 45-year-old male, admitted for depression. Recent medication change. B: Patient has been stable on sertraline 100mg daily for several months. New medication, buspirone 10mg twice daily, was started 24 hours ago. R: At 07:00, patient became increasingly restless, agitated, and confused. Noted to have muscle rigidity, hyperreflexia, and a temperature of 39.2째C (102.6째F). Heart rate 120 bpm, BP 160/100 mmHg. Patient is diaphoretic. A: Concern for serotonin syndrome due to the addition of buspirone to existing sertraline therapy. Requesting immediate evaluation and orders for symptomatic management. 07:15 Neuro assessment reveals clonus. 07:20 Noted dilated pupils. 07:25 Auscultation reveals hyperactive bowel sounds. 07:30 Patient reports nausea and headache."
            },
            {
                "tabTitle": "Vitals",
                "tabContent": "BP: 160/100 mmHg, HR: 120 bpm, RR: 24, Temp: 39.2째C (102.6째F), SpO2: 96% on room air"
            },
            {
                "tabTitle": "Labs",
                "tabContent": "WBC: 9,000/mm3, Na: 140 mEq/L, K: 4.2 mEq/L, Creatinine: 1.0 mg/dL, Glucose: 110 mg/dL, CK: 200 U/L"
            },
            {
                "tabTitle": "Exam",
                "tabContent": "General: Anxious and agitated. Neuro: Muscle rigidity, hyperreflexia, clonus, dilated pupils. GI: Hyperactive bowel sounds. Skin: Diaphoretic."
            },
            {
                "tabTitle": "Orders",
                "tabContent": "Sertraline 100mg PO daily, Buspirone 10mg PO BID (started yesterday), Acetaminophen 650mg PO PRN for fever, IV fluids 0.9% NS at 50 mL/hr"
            },
            {
                "tabTitle": "MAR",
                "tabContent": "Sertraline 100mg PO given at 08:00, Buspirone 10mg PO given at 08:00 (yesterday) and 20:00 (yesterday), Acetaminophen 650mg PO not administered"
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "analyze",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 5,
        "topicTags": [
            "Serotonin Syndrome",
            "Neuroleptic Malignant Syndrome",
            "Pharmacology",
            "Adverse Effects",
            "Prioritization"
        ]
    },
    "rationale": {
        "correct": "The patient is exhibiting signs and symptoms consistent with serotonin syndrome, including agitation, confusion, muscle rigidity, hyperreflexia, clonus, hyperthermia, diaphoresis, and hyperactive bowel sounds. These symptoms have developed shortly after the initiation of buspirone in a patient already taking sertraline, increasing the risk of serotonin syndrome. The priority action is to immediately discontinue the offending medication (buspirone) to prevent further serotonin accumulation. Contacting the healthcare provider is crucial to report the patient's condition and obtain further orders for specific interventions, such as cyproheptadine, a serotonin antagonist, and supportive care.",
        "incorrect": "Administering an antipyretic (b) is a lower priority. While the patient has a fever, the underlying cause is likely related to excessive serotonergic activity, and antipyretics will not address the root cause. Aggressively managing hyperthermia with cooling blankets and ice packs (c) is important, but only after discontinuing the medication. Addressing the cause is the priority. Dantrolene (d) is used in the treatment of neuroleptic malignant syndrome (NMS), not serotonin syndrome. While there may be some overlapping symptoms, the treatment is different.",
        "answerBreakdown": [
            {
                "option": "a",
                "analysis": "Correct. This addresses the underlying cause and allows for further treatment decisions. Discontinuing the medication is the priority."
            },
            {
                "option": "b",
                "analysis": "Incorrect. This addresses a symptom but not the underlying cause. While fever management is important, it is not the priority."
            },
            {
                "option": "c",
                "analysis": "Incorrect. This addresses a symptom but not the underlying cause, and is secondary to discontinuing the medication. Hyperthermia management is important but follows medication discontinuation."
            },
            {
                "option": "d",
                "analysis": "Incorrect. This is the incorrect treatment for serotonin syndrome; it's used for NMS. Using dantrolene could be harmful."
            }
        ],
        "clinicalPearls": [
            "Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the central nervous system.",
            "Common causes include the use of multiple serotonergic medications, drug interactions, and overdose.",
            "Symptoms can include agitation, confusion, muscle rigidity, hyperreflexia, hyperthermia, diaphoresis, and gastrointestinal distress.",
            "The first step in managing serotonin syndrome is to discontinue all serotonergic medications.",
            "Supportive care, such as cooling measures, IV fluids, and benzodiazepines for agitation, may be necessary.",
            "In severe cases, cyproheptadine, a serotonin antagonist, may be administered."
        ],
        "questionTrap": {
            "trap": "The question trap lies in confusing the symptoms of serotonin syndrome with those of neuroleptic malignant syndrome (NMS). Both conditions can present with hyperthermia and muscle rigidity.",
            "howToOvercome": "Carefully assess the patient's medication history. Serotonin syndrome is more likely to occur with serotonergic medications, while NMS is associated with antipsychotic medications. Also, clonus is more specific to serotonin syndrome, while lead-pipe rigidity is more common in NMS. The rapid onset after starting a new serotonergic medication is a key clue here. Review the MAR and SBAR tabs."
        },
        "mnemonic": {
            "title": "SHIVERS",
            "expansion": "Shivering, Hyperreflexia and myoclonus, Increased temperature, Vital sign instability, Encephalopathy, Restlessness, Sweating"
        }
    },
    "scoring": {
        "method": "dichotomous",
        "maxPoints": 1
    },
    "sentinelStatus": "healed_v2026_v11"
}